Tool for risk assessment of nanomaterials in cosmetics Both regulators and manufacturers need to evaluate and manage consumer health risks that may be posed by the use of nanomaterials in cosmetics.
RIVM to research safe design for new nanoparticles RIVM will be working alongside a consortium of 23 international partners on a safe design for ‘new’ nanoparticles.
New bacterium in ticks Last year, a man was treated at the Amsterdam Academic Medical Centre (AMC) after being bitten by a tick and becoming infected with a strain of the Borrelia bacterium not previously encountered in